Remote patient control may reduce the need to hospitalize cancer patients


A study by researchers at the Mayo Clinic Cancer Center found that cancer patients diagnosed with COVID-19 who received home care through remote monitoring of patients were significantly less likely to require hospitalization for their disease, compared with cancer patients with COVID-19 who did not. participate in the program. The results of the study were presented Friday, June 4, at the annual meeting of the American Society of Clinical Oncology and published in the Journal of Clinical Oncology.

“For our study, we evaluated 224 cancer patients at the Mayo Clinic who were diagnosed with COVID-19 using standardized screening before receiving , or because of symptoms or near exposure, “says Tufia Haddad, MD, a medical oncologist at the Mayo Clinic and lead author of the study. The researchers followed patients from March 18 to July 31, 2020.

Dr. Haddad says that at the beginning of the COVID-19 pandemic, Mayo Clinic quickly developed and implemented a remote patient control program to support Mayo Clinic patients who were diagnosed with COVID-19 and at risk. to suffer .

The program included the use of home technology to monitor , and symptoms of COVID-19 infection, and a centralized virtual care team of nurses and physicians to manage patients. Dr. Haddad says the program had cared for more than 8,000 patients in rural and urban locations in 41 states by November 2020.

The researchers found that among patients who did not need urgent hospitalization at the time of COVID-19 diagnosis, those who received care through the remote patient monitoring program were significantly less likely to require hospitalization for their disease, compared to those that were not managed by the program.

“After balancing the two groups of patients who were managed or not by the remote control program of known factors affecting COVID-19 outcomes, such as old age, male gender, and obesity, it was reduced to 78 % the risk of hospitalization (a 2.8% risk for patients in the remote monitoring program, compared to 13% for patients who are not part of the program) attributed to the remote monitoring program, “says Dr. . Haddad.

Also, Dr. Haddad says that when which had been managed via the remote control were hospitalized, experienced fewer hospitalizations of more than a week, ICU admissions, and deaths.

“It is possible that our results were due to the early detection of adverse symptoms and trends in vital signs that allowed previous care interventions to alter the course of the disease.” The results are encouraged by Dr. Haddad, but he warns that more research will be needed to confirm them.

Fatigue, mood disorders associated with post-COVID-19 syndrome

Citation: Remote Patient Control May Reduce the Need to Hospitalize Cancer Patients (2021, June 4) Retrieved June 4, 2021 at -cancer-patients.html

This document is subject to copyright. Apart from any fair treatment for private study or research purposes, no part may be reproduced without written permission. Content is provided for informational purposes only.

Source link